Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Related Citations for PubMed (Select 18606449)

1.

Bone marrow cell cycle markers in inherited bone marrow failure syndromes.

Al-Rahawan MM, Alter BP, Bryant BJ, Elghetany MT.

Leuk Res. 2008 Dec;32(12):1793-9. doi: 10.1016/j.leukres.2008.05.020. Epub 2008 Jul 7.

2.

Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.

Kanavaros P, Stefanaki K, Rontogianni D, Darivianaki K, Vlychou M, Papadaki E, Eliopoulos G, Bakiri M, Matsouka C, Kakolyris S, Georgoulias V.

Clin Exp Pathol. 1999;47(5):231-8.

PMID:
10598372
3.

Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.

Venkatraj VS, Gaidano G, Auerbach AD.

Leukemia. 1994 Aug;8(8):1354-8.

PMID:
8057673
5.

Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.

Mehta PA, Harris RE, Davies SM, Kim MO, Mueller R, Lampkin B, Mo J, Myers K, Smolarek TA.

Cancer Genet Cytogenet. 2010 Dec;203(2):180-6. doi: 10.1016/j.cancergencyto.2010.07.127.

PMID:
21156231
6.

Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome.

Boehrer S, Adès L, Tajeddine N, Hofmann WK, Kriener S, Bug G, Ottmann OG, Ruthardt M, Galluzzi L, Fouassier C, Tailler M, Olaussen KA, Gardin C, Eclache V, de Botton S, Thepot S, Fenaux P, Kroemer G.

Oncogene. 2009 Jun 4;28(22):2205-18. doi: 10.1038/onc.2009.69. Epub 2009 Apr 27.

PMID:
19398952
7.

Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.

Shimazaki K, Ohshima K, Suzumiya J, Kawasaki C, Kikuchi M.

Br J Haematol. 2000 Sep;110(3):584-90.

PMID:
10997968
8.

Bone marrow cells of myelodysplastic syndromes exhibit significant expression of apollon, livin and ILP-2 with reduction after transformation to overt leukemia.

Abe S, Yamamoto K, Hasegawa M, Inoue M, Kurata M, Hirokawa K, Kitagawa M, Nakagawa Y, Suzuki K.

Leuk Res. 2005 Sep;29(9):1095-6. Epub 2005 Mar 16. No abstract available.

PMID:
16038738
9.

[Abnormalities of CD34+ cells differentiation and bone marrow cell cycle in myelodysplastic syndrome].

Li LJ, Fu R, Shao ZH, Wang HQ, Yue LZ, Ruan EB, Liu H, Wang J, Wang HL.

Zhonghua Nei Ke Za Zhi. 2010 Nov;49(11):963-6. Chinese.

PMID:
21211213
10.

The proliferation index of specific bone marrow cell compartments from myelodysplastic syndromes is associated with the diagnostic and patient outcome.

Matarraz S, Teodosio C, Fernandez C, Albors M, Jara-Acevedo M, López A, Gonzalez-Gonzalez M, Gutierrez ML, Flores-Montero J, Cerveró C, Pizarro-Perea M, Paz Garrastazul M, Caballero G, Gutierrez O, Mendez GD, González-Silva M, Laranjeira P, Orfao A.

PLoS One. 2012;7(8):e44321. doi: 10.1371/journal.pone.0044321. Epub 2012 Aug 31.

11.

Recent insights into inherited bone marrow failure syndromes.

Parikh S, Bessler M.

Curr Opin Pediatr. 2012 Feb;24(1):23-32. doi: 10.1097/MOP.0b013e32834eca77. Review.

12.

Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.

Alter BP, Giri N, Savage SA, Peters JA, Loud JT, Leathwood L, Carr AG, Greene MH, Rosenberg PS.

Br J Haematol. 2010 Jul;150(2):179-88. doi: 10.1111/j.1365-2141.2010.08212.x. Epub 2010 Apr 30.

13.

Ribosomal protein S14 silencing inhibits growth of acute myeloid leukemia transformed from myelodysplastic syndromes via activating p53.

Wang L, Luo J, Nian Q, Xiao Q, Yang Z, Liu L.

Hematology. 2014 Jun;19(4):225-31. doi: 10.1179/1607845413Y.0000000127. Epub 2013 Nov 25.

PMID:
24074450
14.

Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.

Gianelli U, Fracchiolla NS, Cortelezzi A, Pellegrini C, Savi F, Moro A, Grimoldi MG, Deliliers GL, Coggi G, Bosari S.

Ann Hematol. 2007 Mar;86(3):185-9. Epub 2006 Nov 24.

PMID:
17124585
15.

Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.

Rosenberg PS, Alter BP, Ebell W.

Haematologica. 2008 Apr;93(4):511-7. doi: 10.3324/haematol.12234. Epub 2008 Mar 5.

16.

Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.

Pülhorn H, Herrmann M, Harms H, Jung A, Baumann I.

Histopathology. 2012 Aug;61(2):200-11. doi: 10.1111/j.1365-2559.2012.04209.x. Epub 2012 Jun 13.

PMID:
22690734
17.

CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.

Abe-Suzuki S, Kurata M, Abe S, Onishi I, Kirimura S, Nashimoto M, Murayama T, Hidaka M, Kitagawa M.

Lab Invest. 2014 Nov;94(11):1212-23. doi: 10.1038/labinvest.2014.110. Epub 2014 Sep 8.

PMID:
25199050
18.
19.

[Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].

Zhang Z, Xie J.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Jun;11(3):274-7. Chinese.

PMID:
12844412
20.

[Expressions of survivin, Bcl-2 and VEGF in patients with myelodysplastic syndrome and their relationship].

Sun H, Ma J, Sun L, Liu LX, Zhao LM.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Apr;14(2):271-5. Chinese.

PMID:
16638195
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk